Cochrane Abstracts
Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft‐versus‐host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Mesenchymal Stromal Cells as Treatment or Prophylaxis for Acute or Chronic Graft‐versus‐host Disease in Haematopoietic Stem Cell Transplant (HSCT) Recipients With a Haematological Condition." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432099/all/Financial_benefits_for_child_health_and_well‐being_in_low_income_or_socially_disadvantaged_families_in_developed_world_countries_Edited__no_change_to_conclusions_. Accessed 11 December 2023.
Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft‐versus‐host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432099/all/Financial_benefits_for_child_health_and_well‐being_in_low_income_or_socially_disadvantaged_families_in_developed_world_countries_Edited__no_change_to_conclusions_. Accessed December 11, 2023.
Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft‐versus‐host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432099/all/Financial_benefits_for_child_health_and_well‐being_in_low_income_or_socially_disadvantaged_families_in_developed_world_countries_Edited__no_change_to_conclusions_
Mesenchymal Stromal Cells as Treatment or Prophylaxis for Acute or Chronic Graft‐versus‐host Disease in Haematopoietic Stem Cell Transplant (HSCT) Recipients With a Haematological Condition [Internet]. In: Cochrane Abstracts. [cited 2023 December 11]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432099/all/Financial_benefits_for_child_health_and_well‐being_in_low_income_or_socially_disadvantaged_families_in_developed_world_countries_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft‐versus‐host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition
ID - 432099
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432099/all/Financial_benefits_for_child_health_and_well‐being_in_low_income_or_socially_disadvantaged_families_in_developed_world_countries_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -
